Cellumed Co. Ltd (049180) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Based on the latest financial reports, Cellumed Co. Ltd (049180) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-294.63 Million ≈ $-199.67K USD) by net assets (₩16.52 Billion ≈ $11.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 049180 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Cellumed Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Cellumed Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cellumed Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cellumed Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Goldbank Mining Corp V:GLB	0.001x
SANGBO Corp KQ:027580	-0.080x
Rhone Ma Holdings Bhd KLSE:5278	0.234x
BioSmart Co.Ltd KQ:038460	0.042x
JERSEY OIL+GAS PLC LS-01 F:TPC1	N/A
Youil Energy Technology Co. Ltd. KQ:340930	-0.002x
SBF AG F:CY1K	N/A
AViTA Corporation TWO:4735	0.043x

Annual Cash Flow Conversion Efficiency for Cellumed Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Cellumed Co. Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 049180 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩8.78 Billion ≈ $5.95 Million	₩-418.53 Million ≈ $-283.63K	-0.048x	+79.65%
2023-12-31	₩23.02 Billion ≈ $15.60 Million	₩-5.40 Billion ≈ $-3.66 Million	-0.234x	-48.97%
2022-12-31	₩53.94 Billion ≈ $36.56 Million	₩-8.49 Billion ≈ $-5.75 Million	-0.157x	+30.01%
2021-12-31	₩47.99 Billion ≈ $32.52 Million	₩-10.79 Billion ≈ $-7.31 Million	-0.225x	-108.37%
2020-12-31	₩28.10 Billion ≈ $19.04 Million	₩-3.03 Billion ≈ $-2.05 Million	-0.108x	-218.21%
2019-12-31	₩5.18 Billion ≈ $3.51 Million	₩472.90 Million ≈ $320.48K	0.091x	+217.96%
2018-12-31	₩23.02 Billion ≈ $15.60 Million	₩-1.78 Billion ≈ $-1.21 Million	-0.077x	+43.15%
2017-12-31	₩37.28 Billion ≈ $25.27 Million	₩-5.07 Billion ≈ $-3.44 Million	-0.136x	-48.08%
2016-12-31	₩46.56 Billion ≈ $31.55 Million	₩-4.28 Billion ≈ $-2.90 Million	-0.092x	+17.86%
2015-12-31	₩41.27 Billion ≈ $27.97 Million	₩-4.62 Billion ≈ $-3.13 Million	-0.112x	+15.92%
2014-12-31	₩44.01 Billion ≈ $29.83 Million	₩-5.86 Billion ≈ $-3.97 Million	-0.133x	-1907.43%
2013-12-31	₩49.20 Billion ≈ $33.34 Million	₩362.28 Million ≈ $245.51K	0.007x	-15.57%
2012-12-31	₩48.75 Billion ≈ $33.04 Million	₩425.13 Million ≈ $288.10K	0.009x	-69.52%
2011-12-31	₩31.75 Billion ≈ $21.52 Million	₩908.37 Million ≈ $615.59K	0.029x	--

About Cellumed Co. Ltd

KQ:049180 Korea Medical Instruments & Supplies

Market Cap

$37.57 Million

₩55.44 Billion KRW

Market Cap Rank

#23005 Global

#1525 in Korea

Share Price

₩1009.00

Change (1 day)

-9.10%

52-Week Range

₩570.00 - ₩2570.00

All Time High

₩36700.00